New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results ...

New preclinical data demonstrates that CMV antigens identified with Evaxion's AI-Immunology platform trigger targeted immune responses Results also showcase the successful design of a proprietary pref ...

Evaxion Biotech (EVAX) has released an update. Evaxion Biotech has unveiled promising preclinical results for its cytomegalovirus vaccine ...

研究者Daniel ...

John Doyle, 60, suffered complications after his transplant and could have been saved, but senior doctors - under pressure ...

NHS staff missed the chance to save a patient because of junior doctors’ strikes, an inquest heard.John Doyle’s death could ...

Groundbreaking bone marrow transplant saves 10-month-old boy with rare genetic immunodeficiency, funded by The Hans Foundation.

EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...

There were protesters outside the office shouting at me and my husband. We wanted and loved our baby, and these people had no ...

Expansion of antigen-specific T cells (cytomegalovirus) counts for reduced repertoire diversity. B-cell functions are altered with age: antibody production, affinity and isotype switching.

But those kinds of risk factors aren’t enough on their own. People have to be exposed to one or more “triggers” that tip the ...

Georgia is expecting a “typical” respiratory virus season for Covid, flu, and RSV, the state public health department has ...